Market revenue in 2024 | USD 30.9 million |
Market revenue in 2030 | USD 87.5 million |
Growth rate | 19.2% (CAGR from 2025 to 2030) |
Largest segment | Pre-commercial/ r&d scale |
Fastest growing segment | Commercial Scale |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pre-commercial/ R&D Scale, Commercial Scale |
Key market players worldwide | Miltenyi Biotec, Lonza Group Ltd, Fresenius SE & Co KGaA, Cytiva, Terumo Corp, Sartorius AG, ThermoGenesis Holdings Inc, Thermo Fisher Scientific Inc, Biospherix, Cellares |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to automated and closed cell therapy processing systems market will help companies and investors design strategic landscapes.
Pre-commercial/ r&d scale was the largest segment with a revenue share of 91.59% in 2024. Horizon Databook has segmented the Australia automated and closed cell therapy processing systems market based on pre-commercial/ r&d scale, commercial scale covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia automated and closed cell therapy processing systems market , including forecasts for subscribers. This country databook contains high-level insights into Australia automated and closed cell therapy processing systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account